Amended Statement of Beneficial Ownership (sc 13d/a)
April 14 2021 - 1:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
OPTIMIZERX CORPORATION
(Name of Issuer)
Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)
68401U105
(CUSIP Number)
Shawn Turner
Holland & Knight LLP
1801 California Street, Suite 5000
Denver, Colorado 80202
(303) 974-6660
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 7, 2021
(Date of Event which Requires Filing of This
Statement)
If the filing person has previously filed a statement
on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §240.13d-1(e),
§240.13d-1 (f) or §240.13d-1(g), check the following box ¨.
Note: Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are being sent.
|
*
|
The remainder of this cover page
shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
|
|
|
|
|
|
|
1
|
|
Names of reporting person
Individual Retirement Accounts for the benefit of Ronald L. Chez,
the Chez Family Foundation and Ronald L. Chez Individually
|
2
|
|
Check the appropriate box if a member of a group (see instructions)
(a) ¨ (b) ¨
|
3
|
|
SEC use only
|
4
|
|
Source of funds (see instructions)
PF
|
5
|
|
Check box if disclosure of legal proceedings is required pursuant to
Items 2(d) or 2(e) ¨
|
6
|
|
Citizenship or place of organization
United States of America
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
7
|
|
Sole voting power
737,984
|
|
8
|
|
Shared voting power
0
|
|
9
|
|
Sole dispositive power
737,984
|
|
10
|
|
Shared dispositive power
0
|
11
|
|
Aggregate amount beneficially owned by each reporting person
737,984
|
12
|
|
Check if the aggregate amount in Row (11) excludes certain shares ¨
|
13
|
|
Percent of class represented by amount in Row (11)
4.4%(1)
|
14
|
|
Type of reporting person (see instructions)
IN
|
The undersigned Ronald L. Chez (the “Reporting
Person”) hereby amends his statement on Schedule 13D dated as of February 5, 2015 as amended by Amendment No. 1 to Schedule
13D dated March 25, 2015, Amendment No. 2 to Schedule 13D dated October 27, 2015, Amendment No. 3 to Schedule 13D dated September
27, 2019 and Amendment No. 4 to Schedule 13D dated February 18, 2021 (collectively, the “Schedule 13D”). This statement constitutes
Amendment No. 5 to the Schedule 13D. The purpose of this Amendment No. 5 is to report a greater than 1% decrease in ownership of
the Company’s Common Stock by the Reporting Person, the net impact of which was to reduce the Reporting Person’s beneficial
ownership below 5% of the Company’s outstanding shares of Common Stock. The filing of this Amendment No. 5 represents the final
amendment to the Schedule 13D and constitutes an exit filing for the Reporting Person. Unless otherwise indicated herein, there are no
material changes to the information set forth in the Schedule 13D.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Schedule 13D is hereby amended and
restated in its entirety as follows:
(a) This statement relates to 737,984 shares of
Common Stock owned by the Reporting Person. Based on the Company’s Annual Report on Form 10-K filed on March 8, 2021, 16,806,637
shares of Common Stock were outstanding as of March 3, 2021. Therefore, the 737,984 shares of Common Stock reported on this Schedule 13D
represent approximately 4.4% of the Company’s issued and outstanding shares of Common Stock.
(b) The Reporting Person has the sole power (and
no shared power) to vote, dispose of or direct the disposition of the Securities and any Common Stock resulting from the exercise or conversion
thereof.
(c) During the last 60 days, the Reporting Person
effected the following purchases and sales of the Company’s securities, each through open market transactions, on the dates, in
the amounts, and at the prices per share shown below.
Transactions by Reporting Person’s individual
retirement accounts:
Date
|
Transaction
|
Shares
|
|
Unit Cost
|
2/12/2021
|
Sale
|
500
|
$
|
56.614
|
2/16/2021
|
Sale
|
40000
|
$
|
62.3352
|
2/16/2021
|
Sale
|
20000
|
$
|
62.3352
|
2/17/2021
|
Sale
|
25000
|
$
|
59.026
|
2/17/2021
|
Sale
|
5000
|
$
|
60.756
|
2/17/2021
|
Sale
|
19583
|
$
|
59.026
|
2/18/2021
|
Purchase
|
10000
|
$
|
56.3145
|
2/18/2021
|
Sale
|
10000
|
$
|
57.7402
|
2/22/2021
|
Purchase
|
10000
|
$
|
57.7479
|
2/23/2021
|
Purchase
|
17000
|
$
|
53.5346
|
2/23/2021
|
Sale
|
17000
|
$
|
55.7783
|
2/24/2021
|
Sale
|
10000
|
$
|
56.2549
|
2/25/2021
|
Purchase
|
10000
|
$
|
56.0956
|
2/26/2021
|
Purchase
|
2700
|
$
|
53.387
|
3/1/2021
|
Sale
|
8000
|
$
|
57.8276
|
3/1/2021
|
Sale
|
6000
|
$
|
57.8276
|
3/4/2021
|
Purchase
|
20000
|
$
|
49.244
|
3/5/2021
|
Purchase
|
7000
|
$
|
40.0326
|
3/5/2021
|
Sale
|
7000
|
$
|
43.2829
|
3/12/2021
|
Purchase
|
1133
|
$
|
43.73
|
3/12/2021
|
Sale
|
1133
|
$
|
45.2783
|
3/15/2021
|
Purchase
|
5000
|
$
|
45.8677
|
3/16/2021
|
Purchase
|
5000
|
$
|
50.2767
|
3/16/2021
|
Purchase
|
5000
|
$
|
50.6404
|
3/17/2021
|
Purchase
|
106
|
$
|
52.4599
|
3/18/2021
|
Purchase
|
9900
|
$
|
50.8858
|
3/19/2021
|
Sale
|
5100
|
$
|
51.9394
|
3/26/2021
|
Purchase
|
3489
|
$
|
47.5
|
4/5/2021
|
Sale
|
3000
|
$
|
53.247
|
4/6/2021
|
Sale
|
35000
|
$
|
50.5267
|
4/7/2021
|
Sale
|
25100
|
$
|
50.1018
|
4/8/2021
|
Sale
|
29823
|
$
|
49.302
|
4/9/2021
|
Sale
|
22728
|
$
|
49.0712
|
4/12/2021
|
Sale
|
44960
|
$
|
50.5628
|
(d) Not applicable.
(e) On April 7, 2021, the Reporting Person ceased to beneficially own more than 5% of outstanding shares of Common Stock of the Company.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: April 14, 2021
|
By:
|
/s/ Ronald L. Chez
|
|
|
Ronald L. Chez
|
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Apr 2023 to Apr 2024